List of BioTheryX patents

Patents where

Current Assignee

Name

BioTheryX

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 10040804 Compounds targeting proteins, compositions, methods, and uses thereof	Patent 10040804 was granted and assigned to BioTheryX on August, 2018 by the United States Patent and Trademark Office.	BioTheryX	BioTheryX	United States Patent and Trademark Office	10040804	August 7, 2018
‌ US Patent 10144745 Chimeric compounds targeting proteins, compositions, methods, and uses thereof	Patent 10144745 was granted and assigned to BioTheryX on December, 2018 by the United States Patent and Trademark Office.	BioTheryX	BioTheryX	United States Patent and Trademark Office	10144745	December 4, 2018
‌ US Patent 11345714 Compounds targeting proteins, compositions, methods, and uses thereof		BioTheryX	BioTheryX	United States Patent and Trademark Office	11345714	May 31, 2022
‌ US Patent 9938302 Chimeric compounds targeting proteins, compositions, methods, and uses thereof	Patent 9938302 was granted and assigned to BioTheryX on April, 2018 by the United States Patent and Trademark Office.		BioTheryX	United States Patent and Trademark Office	9938302	April 10, 2018
‌ US Patent 10960003 Pyrazole pyrimidine derivative and uses thereof	Patent 10960003 was granted and assigned to BioTheryX on March, 2021 by the United States Patent and Trademark Office.		BioTheryX	United States Patent and Trademark Office	10960003	March 30, 2021
‌ US Patent 11072599 Pyrazole compounds and uses thereof	Patent 11072599 was granted and assigned to BioTheryX on July, 2021 by the United States Patent and Trademark Office.		BioTheryX	United States Patent and Trademark Office	11072599	July 27, 2021
‌ US Patent 10905684 Aminoamide compounds	Patent 10905684 was granted and assigned to BioTheryX on February, 2021 by the United States Patent and Trademark Office.	BioTheryX	BioTheryX	United States Patent and Trademark Office	10905684	February 2, 2021
‌ US Patent 11400084 Aminoamide compounds		BioTheryX	BioTheryX	United States Patent and Trademark Office	11400084	August 2, 2022
‌ US Patent 10336771 Compounds targeting proteins, compositions, methods, and uses thereof	Patent 10336771 was granted and assigned to BioTheryX on July, 2019 by the United States Patent and Trademark Office.	BioTheryX	BioTheryX	United States Patent and Trademark Office	10336771	July 2, 2019
‌ US Patent 10584133 Thienopyrimidinone compounds	Patent 10584133 was granted and assigned to BioTheryX on March, 2020 by the United States Patent and Trademark Office.	BioTheryX	BioTheryX	United States Patent and Trademark Office	10584133	March 10, 2020
‌ US Patent 10233153 Pyridinethiones, pharmaceutical compositions thereof, and their therapeutic use for treating a proliferative, inflammatory, neurodegenerative, or immune-mediated disease	Patent 10233153 was granted and assigned to BioTheryX on March, 2019 by the United States Patent and Trademark Office.	BioTheryX	BioTheryX	United States Patent and Trademark Office	10233153	March 19, 2019
‌ US Patent 9527815 Hydroxypyridone derivatives, pharmaceutical compositions thereof, and their therapeutic use for treating inflammatory, neurodegenerative, or immune-mediated diseases	Patent 9527815 was granted and assigned to BioTheryX on December, 2016 by the United States Patent and Trademark Office.	BioTheryX	BioTheryX	United States Patent and Trademark Office	9527815	December 27, 2016
‌ US Patent 11236105 Bicyclic compounds and methods of use	Patent 11236105 was granted and assigned to BioTheryX on February, 2022 by the United States Patent and Trademark Office.	BioTheryX	BioTheryX	United States Patent and Trademark Office	11236105	February 1, 2022
‌ US Patent 10406165 Compounds targeting proteins, compositions, methods, and uses thereof	Patent 10406165 was granted and assigned to BioTheryX on September, 2019 by the United States Patent and Trademark Office.	BioTheryX	BioTheryX	United States Patent and Trademark Office	10406165	September 10, 2019
‌ US Patent 10562917 Chimeric compounds targeting proteins, compositions, methods, and uses thereof	Patent 10562917 was granted and assigned to BioTheryX on February, 2020 by the United States Patent and Trademark Office.	BioTheryX	BioTheryX	United States Patent and Trademark Office	10562917	February 18, 2020
‌ US Patent 11352338 Substituted isoindolinones	Patent 11352338 was granted and assigned to BioTheryX on June, 2022 by the United States Patent and Trademark Office.	BioTheryX	BioTheryX	United States Patent and Trademark Office	11352338	June 7, 2022
‌ US Patent 11191769 Fused thiophene compounds	Patent 11191769 was granted and assigned to BioTheryX on December, 2021 by the United States Patent and Trademark Office.	BioTheryX	BioTheryX	United States Patent and Trademark Office	11191769	December 7, 2021
‌ US Patent 9822098 Compounds targeting proteins, compositions, methods, and uses thereof	Patent 9822098 was granted and assigned to BioTheryX on November, 2017 by the United States Patent and Trademark Office.	BioTheryX	BioTheryX	United States Patent and Trademark Office	9822098	November 21, 2017
‌ US Patent 10513515 Ether compounds and uses thereof	Patent 10513515 was granted and assigned to BioTheryX on December, 2019 by the United States Patent and Trademark Office.	BioTheryX	BioTheryX	United States Patent and Trademark Office	10513515	December 24, 2019
‌ US Patent 9546131 Substituted biaryl alkyl amides	Patent 9546131 was granted and assigned to BioTheryX on January, 2017 by the United States Patent and Trademark Office.	BioTheryX	BioTheryX	United States Patent and Trademark Office	9546131	January 17, 2017
‌ US Patent 10889593 Compounds targeting proteins, compositions, methods, and uses thereof	Patent 10889593 was granted and assigned to BioTheryX on January, 2021 by the United States Patent and Trademark Office.	BioTheryX	BioTheryX	United States Patent and Trademark Office	10889593	January 12, 2021
‌ US Patent 10669260 Compounds targeting proteins, compositions, methods, and uses thereof		BioTheryX	BioTheryX	United States Patent and Trademark Office	10669260	June 2, 2020
‌ US Patent 10106491 Substituted biaryl alkyl amides	Patent 10106491 was granted and assigned to BioTheryX on October, 2018 by the United States Patent and Trademark Office.	BioTheryX	BioTheryX	United States Patent and Trademark Office	10106491	October 23, 2018
‌ US Patent 10844039 Substituted isoindolinones	Patent 10844039 was granted and assigned to BioTheryX on November, 2020 by the United States Patent and Trademark Office.	BioTheryX	BioTheryX	United States Patent and Trademark Office	10844039	November 24, 2020
‌ US Patent 9273005 Hydroxypyridone derivatives, pharmaceutical compositions thereof, and their therapeutic use for treating proliferative diseases	Patent 9273005 was granted and assigned to BioTheryX on March, 2016 by the United States Patent and Trademark Office.	BioTheryX	BioTheryX	United States Patent and Trademark Office	9273005	March 1, 2016

Results per page:

35 results

0 selected

35 results

0 selected